A Study to Test the Safety and Tolerability of a New Medication in the Treatment of Schizophrenia

NCT00088621 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Lurasidone 80mg tablet

Sponsor

Sumitomo Pharma America, Inc.